NFKB1 polymorphism is associated with age-related gene methylation in Helicobacter pylori-infected subjects

  • Authors:
    • Tomiyasu Arisawa
    • Tomomitsu Tahara
    • Hisakazu Shiroeda
    • Hideto Yamada
    • Tomoe Nomura
    • Ranji Hayashi
    • Takashi Saito
    • Tomoki Fukuyama
    • Toshimi Otsuka
    • Masakatsu Nakamura
    • Nobuyuki Toshikuni
    • Mutsumi Tsuchishima
    • Tomoyuki Shibata
  • View Affiliations

  • Published online on: May 18, 2012     https://doi.org/10.3892/ijmm.2012.1004
  • Pages: 255-262
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

CpG island aberrant methylation is shown to be an important mechanism in gene silencing. The important role of NF-κB in the inflammatory response to H. pylori colonization has been indicated. We investigated the influence of NFKB1 polymorphisms, -94 ins/del (rs28362491) and -449 C>G (rs72696119), on the aberrant gene methylation under H. pylori infection. Gastric mucosal samples were obtained from sub-subjects without malignancies. Methylation status of genes (p14ARF, p16INK4a, DAPK and CDH1) was determined by methylation-specific PCR (MSP). The genotyping of NFKB1 was performed by PCR-SSCP. There was a strong allelic association between rs28362491 and rs72696119, and all H. pylori-infected -94 del/del homozygotes had a -449 GG genotype. The -94 del/del homozygosity was significantly associated with risk for development of CpG island high methylation (CIHM) (two or more gene methylations), especially DAPK and CDH1 methylations, and the number of methylated genes was significantly higher in -94 del/del homozygotes than in ins/del and ins/ins (ins carrier) H. pylori-infected elder subjects. In addition, this methylated gene number was significantly increased with age in H. pylori-infected del/del homozygotes, but not in infected ins carriers. Furthermore, the inflammation score was significantly higher in H. pylori-infected del/del homozygotes compared to ins carriers. NFKB1 -94 ins/del ATTG polymorphism (rs28362491) was significantly associated with the increased risk for the development of age-related gene methylation in non-cancerous gastric mucosa under H. pylori-induced inflammation.

Introduction

Helicobacter pylori (H. pylori) infection first induces chronic superficial gastritis, which can progress to chronic atrophic gastritis, intestinal metaplasia, and dysplasia that leads toward gastric carcinoma (1). Lipopolysaccharide (LPS), which is a component of the outer membrane of Gram-negative bacteria including H. pylori, is a signaling molecule for the innate immune system and is one of the main sources of inflammation (2). LPS binding to TLR4 activates signal transduction through MyD88, IRAK and TRAF6 to activate NF-κB (3). Activation of NF-κB by H. pylori induces nuclear translocation, which causes an increase in IL-8 messenger RNA and protein levels (4). Other NF-κB responsive genes including pro-inflammatory cytokines have also been found in elevated levels in H. pylori-infected gastric mucosa. In addition, the NF-κB pathway is responsible for the generation of several cell adhesion molecules including ICAM-1 whose expression is significantly correlated with an increase in H. pylori-induced gastritis (5). Thus, H. pylori is a potent activator of NF-κB in gastric epithelial cells and NF-κB is a major molecule in H. pylori-induced inflammation (4,6). On the other hand, NF-κB activation is known to regulate cellular growth responses, including apoptosis, and is required for the induction of inflammatory and tissue-repair genes (7). These facts suggest that NF-κB plays an important role in inflammation-associated carcinogenesis. In fact, H. pylori infection, activating NF-κB, is now accepted as a crucial event in the development of peptic ulcer disease and atrophic gastritis, and it is implicated in the development of gastric carcinoma, especially not located in the cardia (810).

Several cancers, including gastric tumors, show methylations of multiple genes (11,12). Some genes are methylated in non-neoplastic tissues with aging (13,14) and these methylations are also under the influence of chronic inflammation (15,16). In non-cancerous gastric mucosa, methylation of CpG islands was induced by H. pylori infection (17,18) and considered as the precancerous conditions in gastric carcinogenesis (19). Among several genes, E-cadherin (CDH1), death-associated protein kinase (DAPK) and cyclin-dependent kinase inhibitor 2A (CDKN2A) are frequently methylated in non-neoplastic gastric mucosa in relation to age, H. pylori infection, histological degree of gastritis, and gastric carcinogenesis (17,20). Therefore, there is a possibility that NF-κB activation may affect the gene methylations in H. pylori-induced chronic inflammation. Recently, many studies have reported the association between the polymorphism, −94 ins/del ATTG (rs28362491) of NFKB1 encoding NF-κB, and various inflammatory diseases (21), as well as malignant neoplasm (22). However, these results do not always lead to the same conclusions. Furthermore, the genetic variation −449 C>G in the 5′-UTR of NFKB1 (rs72696119) has been identified. There are no reports for the association of this polymorphism and human disorders.

Then, we attempted to clarify the association between the −94 ins/del ATTG polymorphism (rs28362491) of NFKB1 and gene methylations in H. pylori-infected Japanese subjects. In addition, the −449 C>G polymorphism (rs72696119) was also investigated.

Materials and methods

Clinical samples

The 330 H. pylori-infected subjects without peptic ulcers and gastric malignancies, who were enrolled at the Endoscopy Center of Fujita Health University Hospital or Kanazawa Medical University Hospital from January in 2006 to December in 2009, were selected. As a control, 205 H. pylori-uninfected subjects were randomly selected from our stocked DNA collected during the same period. Thus, the overall studied population comprised 535 subjects.

All subjects underwent upper endoscopy with biopsy from non-cancerous mucosa in the antrum. Parts of each specimen was fixed in 10% buffered-formalin and embedded in paraffin, while the other part was immediately frozen and stored at −85°C. Later, genomic DNA was isolated from frozen specimens using proteinase K. The patients with severe systemic diseases, malignancies in other organs, and who had received nonsteroidal anti-inflammatory drugs, antibiotics, and H. pylori eradication treatment were excluded. H. pylori infection status was assessed by serology, histological examination, or the urea breath test. Patients were diagnosed as having infection when at least one of the diagnostic tests was positive.

The subjects with 2 or more methylations of 4 genes (p14ARF, p16INK4a, DAPK and CDH1) were classified into the CpG island high methylation (CIHM) group, whereas the others except the CIHM group were classified into the non-CIHM group.

The Ethics Committee of the Fujita Health University and the Kanazawa Medical University approved the protocol, and prior, written informed consent was obtained from all participating subjects.

Bisulfate modification and methylation-specific PCR (MSP)

In 402 of 535 subjects (243 H. pylori-infected and 159 uninfected), the methylation status of 4 candidate promoter CpG islands (p14, p16, CDH1, and DAPK), which have been thought to be most susceptible for methylation in the stomach (12,19,22,23), were assessed. For the examination of DNA methylation, genomic DNA was treated with sodium bisulfite using the BislFast DNA Modification kit for methylated DNA detection (Toyobo, Co., Ltd., Osaka, Japan). Methylation status of four candidate promoter CpG islands were examined by MSP as previously described (24). The primer pairs and experimental conditions for MSP are the same as in our previous study (13,23,24). The MSP was carried out in a volume of 20 μl containing 0.1 μg of bislufite-modified DNA. The bands of MSP were detected by electrophoresis in 3.0% agarose gels stained with ethidium bromide. Hypermethylation was defined as the presence of positive methylation band, separated by electrophoresis on 2.5% agarose gels under UV illumination using an ethidium bromide staining, showing signals approximately equivalent to or greater than that of size marker (10 ng/μl: 100 bp DNA ladder; Takara Bio, Inc., Shiga, Japan), irrespective of the presence of unmethylated bands. We used DNA from the peripheral blood of a young individual without H. pylori infection, as the negative control (unmethylated DNA), and also used DNA being treated with SssI methylase (New England Biolabs, Inc., Beverly, MA, USA), as the positive control (methylated DNA). Samples giving faint positive signals were analyzed a further two times and only those samples with consistent positive methylation band were considered as hypermethylation status.

Genotyping of polymorphisms

The DNA isolated from biopsy specimens or peripheral blood was used. The polymorphisms were genotyped by the PCR-SSCP method as previously described (25,26). To detect NFKB1 −94 ins/del ATTG using the primer pairs (94-F, 5′-gctatggaccgcatgactctatcag-3′ and 94-R, 5′-ggggctctggcttcctagcag-3′), PCR was carried out in a volume of 20 μl containing 0.1 μg of genomic DNA. The DNA was denatured at 95°C for 3 min, followed by 35 cycles at 96°C for 15 sec, 58°C for 40 sec, and 72°C for 30 sec, with a final extension at 72°C for 5 min. Thereafter, 2 μl of the PCR product was denatured with 10 μl of formamide (Sigma-Aldrich Co., St. Louis, MO, USA) at 90°C for 5 min. SSCP was carried out at 6°C using a GenePhor DNA separation system with GeneGel Excel 12.5/24 (Amersham Biosciences Corp., USA), after which the denatured single strand DNA bands were detected using a DNA Silver Staining kit (Amersham Biosciences Corp.).

To detect the NFKB1 −449 C>G, using the primer pairs (449-F, 5′-cgtgtgtccgtctgtctgtatgctc-3′ and 449-R, 5′-cgctggtgcacttctctctctttct-3′), PCR was carried out in a volume of 20 μl containing 0.1 μg of genomic DNA. The DNA was denatured at 95°C for 3 min, followed by 35 cycles at 95°C for 30 sec, 57°C for 40 sec, and 72°C for 45 sec, with a final extension at 72°C for 5 min. Thereafter, SSCP was carried out as described above.

Histological evaluation

In 400 of 535 subjects (256 H. pylori-infected and 144 uninfected subjects), the severity of chronic gastritis was classified according to the updated Sydney system (27) by a pathologist who had no access to any clinical information.

Statistical analysis

The data were expressed as mean ± SD. The mean age among the two groups was compared by the Student’s t-test. The ratios of gender and gene methylation were compared by the Fisher’s extract test. The strength of association between allele frequencies and the methylation status was assessed by calculating the odds ratio (OR) and 95% confidence intervals (CI) by logistic regression analysis. Adjusted ORs were calculated after adjustment for age and gender. Each updated Sydney system score between the 2 groups were compared by the Mann-Whitney U-test. The methylation status was compared among the 2 groups by ANOVA. The relationship between age and the number of methylated genes was also assessed by ANOVA. Concerning the power of study, the β-value was calculated when setting α=0.05. For all analyses, the level of significance was set at p<0.05.

Results

Subjects and genotype

As shown in Fig. 1, single strand DNAs of each polymorphism were clearly identified by SSCP. The characteristics of the subjects are summarized in Table I. The overall distribution of −94 ins/del ATTG genotype was 198 ins/ins, 269 ins/del and 68 del/del. The distribution of −449 C>G was 207 CC, 252 CG and 76 GG. There was a strong allelic association between −94 ins/del ATTG and −449 C>G. The frequencies of distributions of both genotypes, in the Hardy-Weinberg equilibrium (p=0.12 and 1.00, respectively), were not significant difference among H. pylori-infected a d uninfected subjects. The male/female ratio was lower and each gene methylation ratio, except p14ARF, was higher in H. pylori-infected subjects than uninfected subjects. The CIHM/non-CIHM ratio was also significantly higher in H. pylori-infected subjects.

Table I

Characteristics and prevalence polymorphisms and methylation status.

Table I

Characteristics and prevalence polymorphisms and methylation status.

CharacteristicsH. pylori-infectedH. pylori-uninfectedp-valuea
Number of subjects330205
Mean age ± SD61.0±12.459.2±15.0NS
Male:female211:11998:1070.0003
NFKB1−94 ins/del ATTG
  ins/ins11979
  ins/del17297
  del/del3929
  del allele frequency37.9%37.8%NS
NFKB1−449 G>C
  CC12483
  CG16191
  GG4531
  G allele frequency38.0%37.3%NS
Methylated:unmethylated
  p14ARF90:15344:1150.053
  p16INK4a91:15221:138<0.0001
  CDH1109:13438:121<0.0001
  DAPK139:10458:101<0.0001
CIHM/non-CIHM136/10747/112<0.0001

a H. pylori-infected vs. H. pylori-uninfected. NS, not significant; CIHM, CpG island high methylation group.

Association between NFKB1 polymorphisms and CIHM

We defined the subjects with 2 or more gene methylations as the CIHM group, because the overall average number of gene methylation was 1.58. NFKB1 −94 del/del homozygotes had an increased risk for the development of CIHM in H. pylori-infected over 60-year-old subjects (OR, 4.16; 95% CI, 1.14–15.3; p=0.031 and β=0.674) (Table II), although no significant risk was seen in overall infected subjects. In H. pylori-uninfected subjects, there was no association between −94 ins/del ATTG polymorphism and CIHM.

Table II

Association between NFKB1−94 ins/del ATTG polymorphism and CIHM.

Table II

Association between NFKB1−94 ins/del ATTG polymorphism and CIHM.

Genotype (n)
del/del vs. ins carrier
ins/insins/deldel/delOR (95% CI)p-value
H. pylori-infected
  Overall
    Non-CIHM (n=107)405710Reference value-
    CIHM (n=136)5065211.58 (0.698–3.56)0.27
  60≤
    Non-CIHM (n=61)23353Reference value-
    CIHM (n=81)2739154.16 (1.14–15.3)0.031
H. pylori-uninfected
  Overall
    Non-CIHM (n=112)455017Reference value-
    CIHM (n=47)192081.15 (0.456–2.88)0.77
  60≤
    Non-CIHM (n=56)212510Reference value-
    CIHM (n=27)131040.814 (0.228–2.91)0.75

[i] Logistic regression analysis after adjustment for age and gender; CIHM, CpG island high methylation group

The association of −449 G>C with CIHM was similar to that of −94 ins/del ATTG with CIHM (Table III), because both polymorphisms were in strong linkage disequilibrium. So, in H. pylori-infected subjects over 60-years-old, −449 GG homozygote had an increased risk for CIHM (OR, 3.31; 95%CI, 1.04–10.6; p= 0.044).

Table III

Association between NFKB1−449 C>G polymorphism and CIHM.

Table III

Association between NFKB1−449 C>G polymorphism and CIHM.

Genotype (n)
GG vs. C carrier
CCCGGGOR (95% CI)p-value
H. pylori-infected
  Overall
    Non-CIHM (n=107)425213Reference value-
    CIHM (n=136)4865231.30 (0.612–2.74)0.50
  60≤
    Non-CIHM (n=61)25324Reference value-
    CIHM (n=81)2738163.31 (1.04–10.6)0.044
H. pylori-uninfected
  Overall
    Non-CIHM (n=112)484519Reference value-
    CIHM (n=47)182091.14 (0.473–2.75)0.77
  60≤
    Non-CIHM (n=56)232211Reference value-
    CIHM (n=27)121050.939 (0.287–3.07)0.92

[i] Logistic regression analysis after adjustment for age and gender; CIHM, CpG island high methylation group

In H. pylori-infected over 60-year-old subjects, both −94 del/del ATTG and −449 GG homozygote had an increased risk for the development of DAPK methylation (OR, 5.35; 95% CI, 1.17–24.5; p=0.031 and β=0.726; and OR, 3.75; 95% CI, 1.04–13.6; p=0.044, respectively) (Table IV). In addition, −94 del/del homozygote had an increased risk for CDH1, as well as DAPK, methylation (OR, 2.91; 95% CI, 1.02–8.30; p=0.046). On the other hand, both polymorphisms were not associated with CDKN2A (p14ARF and p16INK4a) methylation.

Table IV

Associations between NFKB1 polymorphisms and each gene methylation in the H. pylori-infected subjects older than 60-year-old.

Table IV

Associations between NFKB1 polymorphisms and each gene methylation in the H. pylori-infected subjects older than 60-year-old.

−94 ATTG ins/delins/insins/deldel/deldel/del vs. ins carrier; OR (95% CI)p-value

p14ARF-unmethylated (n=86)353912Reference value-
p14ARF-methylated (n=56)153560.661 (0.228–1.92)0.45
p16INK4a-unmethylated (n=90)29529Reference value-
p16INK4a-methylated (n=52)212291.83 (0.671–4.97)0.24
CDH1-unmethylated (n=79)29446Reference value-
CDH1-methylated (n=63)2130122.91 (1.02–8.30)0.046
DAPK-unmethylated (n=53)19322Reference value-
DAPK-methylated (n=89)3142165.35 (1.17–24.5)0.031

−449 C>GCCCGGGGG vs. C carrier; OR (95% CI)p-value

p14ARF-unmethylated (n=86)373712Reference value-
p14ARF-methylated (n=56)153380.925 (0.346–2.48)0.88
p16INK4a-unmethylated (n= 90)314811Reference value-
p16INK4a-methylated (n=52)212291.45 (0.555–3.81)0.45
CDH1-unmethylated (n=79)31408Reference value-
CDH1-methylated (n=63)2130122.12 (0.802–5.59)0.13
DAPK-unmethylated (n=53)20303Reference value-
DAPK-methylated (n=89)3240173.75 (1.04–13.6)0.044

[i] Logistic regression analysis after adjustment for age and gender.

Relationship between NFKB1 polymorphisms and methylated gene number

We found strong allelic association between −94 ins/del ATTG and −449 C>G. That is, 66 of 68 del/del homozygote had −449 GG genotype. In H. pylori-infected subjects, all of 39 del/del homozygote had −449 GG genotype. Therefore, we investigated the association of only −94 ins/del ATTG polymorphism with gastric inflammation and gene methylation. In H. pylori-infected subjects over 60-years-old or more, methylated gene number was significantly higher in del/del homozygotes than in ins carriers (p=0.040 by ANOVA) (Fig. 2), although no significant difference was seen in overall H. pylori-infected subjects. In H. pylori-uninfected subjects, there was no significant difference in the methylated gene number among two genotypes.

In H. pylori-infected del/del homozygote, methylated gene number was significantly correlated to age (p= 0.027 by ANOVA) (Fig. 3), whereas no significant correlation was seen in the H. pylori-infected ins carrier and the uninfected groups.

Comparison of each updated Sydney system score among del-G and non-del-G groups

In H. pylori-infected subjects, the inflammation score was significantly higher in del/del homo-zygote than ins carrier (p=0.0091 by Mann-Whitney U-test), whereas the other scores were not different among two genotypes (Table V). In H. pylori-uninfected subjects, there were no significant differences of all scores among two genotypes.

Table V

Comparison of each updated Sydney system score among del/del and ins carrier.

Table V

Comparison of each updated Sydney system score among del/del and ins carrier.

H. pylori-infecteddel/del (n=28)ins carrier (n=228)p-value

  Activity0.929±0.8130.851±0.858NS
  Inflammation2.179±0.4761.860±0.6280.0091
  Atrophy1.607±0.6851.575±0.773NS
  Metaplasia0.786±1.0670.982±1.015NS

H. pylori-uninfecteddel/del (n=15)ins carrier (n=129)p-value

  Activity0.067±0.2580.155±0.441NS
  Inflammation0.533±0.5160.659±0.667NS
  Atrophy0.133±03520.326±0.614NS
  Metaplasia00.109±0.437NS

[i] Statistical anaysis was performed by the Mann-Whitney U-test. NS, not significant.

Discussion

Accumulation of DNA damage and aberrant methylation of various genes in gastric mucosa were induced by H. pylori infection and confer risk for developing gastric cancer. However, all the H. pylori-infected patients do not show the same hypermethylation status of genes. This suggests that some host genetic factor, such as genetic variations related to the immune response or inflammation, may be relevant to the hypermethylation of genes during gastric carcinogenesis.

Here, we evaluated the association between NFKB1, encoding NF-κB which plays an important role in inflammation and carcinogenesis, polymorphisms and aberrant methylation of genes in non-neoplastic gastric mucosa. NFKB1 −94 ins/del ATTG and −449 C>G was in linkage disequilibrium and all of 39 H. pylori-infected −94 del/del homozygote had the −449 GG genotype. Therefore, the effects of the −94 and −449 mutant haplotype was equal to that of the −94 mutant variation. In the present study, we demonstrated that the −94 del/del ATTG homozygotes had increased risk of aberrant methylation of DAPK and CDH1 in comparatively older H. pylori-infected subjects. We also found that in H. pylori-infected del/del homozygotes, the number of methylated genes was higher in subjects over 60-years-old and was correlated to age. In addition, gastric mucosal inflammation was more severe in infected del/del homozygotes. These findings suggest that, in the NFKB1 −94 del/del ATTG homozygote, H. pylori infection may accelerate severe mucosal inflammation, resulting in high age-related gene methylation. The methylation of genes is frequently observed in H. pylori-infected non-neoplastic mucosa (1719), and is closely correlated with gastric cancer occurrence (12,18,20). Therefore, this epigenetic effect seems to be an early step in carcinogenesis in the stomach. Our data suggest that NFKB1 polymorphisms may have a role in gastric carcinogenesis in the early phase via gene methylation-related pathway. In the present study, sample selection may affect the outcome, because our subjects came to hospital in order to have endoscopic examination for the compliant of abdominal discomfort, or for complete check up of gastric cancer following to barium X-ray examination in the health check, not complete healthy subjects. Moreover, the effect of type II error cannot be excluded in relatively small sample sizes. Another limitation of this study was that the male/female ratio was different among H. pylori-infected and uninfected subjects. However, adjustment of age and gender was performed in genotype analysis using logistic regression.

It has been reported that the NFKB1 −94 ATTG deletion variant in the promoter region destroys a transcription factor binding site, resulting in lower expression of NF-κB (28). Due to their important role in inflammation, the lower expression of NF-κB protein seems to suppress inflammation. Furthermore, the NFKB1 −94 deletion mutant has been associated with reduced risk for the auto-immune disorders in China (29). In stomach, Lo et al (30) showed that −94 deletion variant had a significantly reduced risk for the gastric carcinogenesis in China. For hepatocarcinogenesis, He et al (31) also showed that −94 deletion mutant had a reduced risk under the influence of hepatitis B virus infection in China. Contrary to these results, several studies have showed that −94 deletion variant is associated with increased risk for the development of inflammatory or auto-immune diseases in Caucasian (28,29,32). In colorectal carcinogenesis, Andersen et al (33) have showed that carriers of NFKB1 −94 deletion were at 1.45-fold higher risk than homozygous carriers of the insertion allele. On the other hand, the lack of an association between the NFKB1 −94 ins/del polymorphism and the inflammatory or autoimmune diseases has also been reported (3437). These contrasting observations may be explained by differences in the genotypic composition of populations in different countries with different racial groups. In fact, the frequency of −94 deletion allele seems to be rather higher in Chinese healthy subjects (45–55%). However, in our study of Japanese subjects, the frequency was ∼38%, similar to the value in Caucasians. Our study as well as the Caucasian study indicate that the −94 deletion variant may be an inflammation promoting allele.

NF-κB encompasses a number of different transcription factors that are homo- or heterodimers of p65, p50, p105, c-Rel and RelB (38). NF-κB is involved in both inflammatory and anti-inflammatory process (39). The role of NF-κB in inflammation is determined by the subunit type. NFKB1 encodes both the subunits p105 and p50 of the transcription factor NF-κB by alternative splicing (40). As part of the p65/p50 NF-κB transcription factor complex, it is pro-inflammatory, controlling transcription of pro-inflammatory cytokines (41). Conversely, since p50 lacks this COOH-terminal transactivation domain which is necessary for the positive regulation of gene expression, p50 has anti-inflammatory properties in the p50 homodimer by repressing transcription (42). The relative abundance of p65/p50 heterodimers and p50 homodimers may determine the magnitude of inflammation by balancing the pro-inflammatory and anti-inflammatory response (38). In fact, p50-deficient mice have an increased sensitivity to lipopolysaccharide (LPS) and have increased LPS-induced inflammation (43,44). In subjects with the del/del genotype, decreased p50 synthesis may lead to decreased repressive homodimers and increased active heterodimers of the NF-κB complex. This balance may promote the H. pylori-induced inflammation, resulting in hypermethylation of genes.

In current study, 66 of 68 del/del homozygotes had the −449 GG genotype and, all of 39 del/del homozygotes had the −449 GG genotype in H. pylori-infected subjects. Therefore, we suspect that −94 ins/del ATTG polymorphism may mainly regulate the expression and function of NF-κB. From our results in this study, we could not show the role of −449 C>G polymorphism. Our results showed that, in −94 del/del homozygote, gastric inflammation was more severe and gene methylation was promoted over 60-year-old under influence of H. pylori infection. Because NF-κB is activated by some stimulation such as infection and stress, it is reasonable that NFKB1 polymorphism is associated with the gastric inflammation process under H. pylori infection. In addition, it is also reasonable that increased gene methylation is revealed in elder subjects, because gene methylation gradually progresses with age and accumulates for a long time. Interestingly, although gastric inflammation was more severe in −94 del/del homozygote, atrophy and metaplasia scores were not different among del/del homozygote and ins carrier. This reason is unclear. The decreased p50 production may affect the action of not only the p50 homodimer but also of the p65/p50 heterodimer.

In conclusion, the NFKB1 −94 ins/del ATTG polymorphism (rs28362491) was significantly associated with an increased risk for the development of age related-gene methylations in non-cancerous gastric mucosa under H. pylori-induced inflammation. The −94 del/del homozygote may have an increased risk for the development of age-related and inflammation-induced gene methylation, as a precancerous condition, in gastric mucosa.

References

1. 

P CorreaHuman gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and PreventionCancer Res52673567401992

2. 

S KiechlE LorenzM ReindlToll-like receptor 4 polymorphisms and atherogenesisN Engl J Med347185192200210.1056/NEJMoa01267312124407

3. 

K HoshinoO TakeuchiT KawaiCutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene productJ Immunol16237493752199910201887

4. 

S KeatesYS HittiM UptonCP KellyHelicobacter pylori infection activates NF-kappa B in gastric epithelial cellsGastroenterology11310991109199710.1053/gast.1997.v113.pm9322504

5. 

RA HatzG RiederM StoltePattern of adhesion molecule expression on vascular endothelium in Helicobacter pylori associated antral gastritisGastroenterology11219081919199710.1053/gast.1997.v112.pm91786839178683

6. 

S MaedaH YoshidaK OguraH. pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cellsGastroenterology11997108200010.1053/gast.2000.8540

7. 

MG SmithGL HoldE TaharaEM El-OmarCellular and molecular aspects of gastric cancerWorld J Gastroenterol12297929902006

8. 

J ParsonnetGD FriedmanDP VandersteenHelicobacter pylori infection and the risk of gastric carcinomaN Engl J Med32511271131199110.1056/NEJM199110173251603

9. 

MJ BlaserJ ParsonnetParasitism by the ‘slow’ bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasiaJ Clin Invest94481994

10. 

JQ HuangS SridharY ChenRH HuntMeta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancerGastroenterology11411691179199810.1016/S0016-5085(98)70422-69609753

11. 

M EstellerPG CornSB BaylinJG HermanA gene hypermethylation profile of human cancerCancer Res6132253229200111309270

12. 

T TaharaT ShibataM NakamuraIncreased number of CpG island hypermethylation in tumor suppressor genes of nonneoplastic gastric mucosa correlates with higher risk of gastric cancerDigestion822736201010.1159/00025276620150736

13. 

JP IssaYL OttavianoP CelanoSR HamiltonNE DavidsonSB BaylinMethylation of the oestrogen receptor CpG island links ageing and neoplasia in human colonNat Genet4536540199410.1038/ng0894-5367951326

14. 

N AhujaQ LiAL MohanSB BaylinJP IssaAging and DNA methylation in colorectal mucosa and cancerCancer Res235489549419989850084

15. 

JP IssaN AhujaM ToyotaMP BronnerTA BrentnallAccelerated age-related CpG island methylation in ulcerative colitisCancer Res6135733577200111325821

16. 

YS BianMC OsterheldC FontollietFT BosmanJ Benhattarp16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett’s esophagusGastroenterology122111311212001

17. 

T MaekitaK NakazawaM MiharaHigh levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer riskClin Cancer Res12989995200616467114

18. 

T TaharaT ArisawaT SibataRisk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epitheliumDigestion755461200710.1159/00010177517438355

19. 

GH KangHJ LeeKS HwangS LeeJH KimJS KimAberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammationAm J Pathol16315511556200310.1016/S0002-9440(10)63511-014507661

20. 

GH KangS LeeJS LimHY JungProfile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesisLab Invest83635641200310.1097/01.LAB.0000067481.08984.3F12746473

21. 

YF ZouF WangXL FengAssociation of NFKB1 −94ins/delATTG promoter polymorphism with susceptibility to auto-immune and inflammatory diseases: a meta-analysisTissue Antigens779172010

22. 

YF ZouFL YuanXL FengAssociation between NFKB1 −94ins/delATTG promoter polymorphism and cancer risk: a meta-analysisCancer Invest2978852010

23. 

T TaharaT ArisawaT ShibataIncreased number of methylated CpG islands correlates with Helicobacter pylori infection, histological and serological severity of chronic gastritisEur J Gastroenterol Hepatol21613619200910.1097/MEG.0b013e32830e28b219307977

24. 

T TaharaT ShibataT ArisawaImpact of catechol-O-methyltransferase (COMT) gene polymorphism on promoter methylation status in gastric mucosaAnticancer Res2928572861200919596974

25. 

T ArisawaT TaharaT ShibataThe relationship between Helicobacter pylori infection and promoter polymorphism of the Nrf2 gene in chronic gastritisInt J Mol Med191431482007

26. 

H ShiroedaT TaharaT ShibataFunctional promoter polymorphisms of macrophage migration inhibitory factor (MIF) in peptic ulcer diseasesInt J Mol Med26707711201020878093

27. 

MF DixonRM GentaJH YardleyP CorreaClassification and grading of gastritis: the updated Sydney systemAm J Surg Pathol2011611181199610.1097/00000478-199610000-000018827022

28. 

AS KarbanT OkazakiCI PanhuysenFunctional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitisHum Mol Genet133545200414613970

29. 

H LiL GaoZ ShenAssociation study of NFKB1 and SUMO4 polymorphisms in Chinese patients with psoriasis vulgarisArch Dermatol Res3004254332008

30. 

SS LoJH ChenCW WuWY LuiFunctional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patientsSurgery1452802852009

31. 

Y HeH ZhangJ YinIκBα gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype CCarcinogenesis30191619222009

32. 

A KurylowiczY HiromatsuB Jurecka-LubienieckaAssociation of NFKB1 −94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves’ diseaseGenes Immun85325382007

33. 

V AndersenJ ChristensenK OvervadA TjønnelandU VogelPolymorphisms in NFκB, PXR, LXR and risk of colorectal cancer in a prospective study of DanesBMC Cancer104842010

34. 

A MartínezE SánchezA ValdiviaEpistatic interaction between FCRL3 and NFkappaB1 genes in Spanish patients with rheumatoid arthritisAnn Rheum Dis6511881191200616476711

35. 

MM MirzaSA FisherC OnnieNo association of the NFKB1 promoter polymorphism with ulcerative colitis in a British case control cohortGut5412051206200516009698

36. 

J GlasHP TörökL TonenchiRole of the NFKB1 −94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genesInflamm Bowel Dis126066112006

37. 

EK BajwaPC CremerMN GongAn NFKB1 promoter insertion/deletion polymorphism influences risk and outcome in acute respiratory distress syndrome among CaucasiansPLoS One6e19469201121573030

38. 

SG PereiraF OakleyNuclear factor-kappaB1: regulation and functionInt J Biochem Cell Biol4014251430200810.1016/j.biocel.2007.05.00417693123

39. 

MP de WintherE KantersG KraalMH HofkerNuclear factor kappaB signaling in atherogenesisArterioscler Thromb Vasc Biol25904914200515731497

40. 

L LinGN DeMartinoWC GreeneCotranslational biogenesis of NF-kappaB p50 by the 26S proteasomeCell92819828199810.1016/S0092-8674(00)81409-99529257

41. 

ND PerkinsIntegrating cell-signalling pathways with NF-kappaB and IKK functionNat Rev Mol Cell Biol84962200710.1038/nrm208317183360

42. 

MS HaydenS GhoshShared principles in NF-kappaB signalingCell132344362200810.1016/j.cell.2008.01.02018267068

43. 

M GadjevaMF TomczakM ZhangA role for NF-kappaB subunits p50 and p65 in the inhibition of lipopolysaccharide-induced shockJ Immunol17357865793200410.4049/jimmunol.173.9.578615494531

44. 

W HanM JooMB EverhartMyeloid cells control termination of lung inflammation through the NF-kappaB pathwayAm J Physiol Lung Cell Mol Physiol296L320L327200910.1152/ajplung.90485.200819098124

Related Articles

Journal Cover

August 2012
Volume 30 Issue 2

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Arisawa T, Tahara T, Shiroeda H, Yamada H, Nomura T, Hayashi R, Saito T, Fukuyama T, Otsuka T, Nakamura M, Nakamura M, et al: NFKB1 polymorphism is associated with age-related gene methylation in Helicobacter pylori-infected subjects. Int J Mol Med 30: 255-262, 2012
APA
Arisawa, T., Tahara, T., Shiroeda, H., Yamada, H., Nomura, T., Hayashi, R. ... Shibata, T. (2012). NFKB1 polymorphism is associated with age-related gene methylation in Helicobacter pylori-infected subjects. International Journal of Molecular Medicine, 30, 255-262. https://doi.org/10.3892/ijmm.2012.1004
MLA
Arisawa, T., Tahara, T., Shiroeda, H., Yamada, H., Nomura, T., Hayashi, R., Saito, T., Fukuyama, T., Otsuka, T., Nakamura, M., Toshikuni, N., Tsuchishima, M., Shibata, T."NFKB1 polymorphism is associated with age-related gene methylation in Helicobacter pylori-infected subjects". International Journal of Molecular Medicine 30.2 (2012): 255-262.
Chicago
Arisawa, T., Tahara, T., Shiroeda, H., Yamada, H., Nomura, T., Hayashi, R., Saito, T., Fukuyama, T., Otsuka, T., Nakamura, M., Toshikuni, N., Tsuchishima, M., Shibata, T."NFKB1 polymorphism is associated with age-related gene methylation in Helicobacter pylori-infected subjects". International Journal of Molecular Medicine 30, no. 2 (2012): 255-262. https://doi.org/10.3892/ijmm.2012.1004